vs

Side-by-side financial comparison of Cushman & Wakefield Ltd. (CWK) and Emerson Electric (EMR). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $2.9B, roughly 1.5× Cushman & Wakefield Ltd.). Emerson Electric runs the higher net margin — 13.9% vs -0.8%, a 14.7% gap on every dollar of revenue. On growth, Cushman & Wakefield Ltd. posted the faster year-over-year revenue change (10.8% vs 4.0%). Emerson Electric produced more free cash flow last quarter ($602.0M vs $234.3M). Over the past eight quarters, Cushman & Wakefield Ltd.'s revenue compounded faster (15.5% CAGR vs -0.4%).

Cushman & Wakefield Inc. is an American global commercial real estate and property management services firm. The company's corporate headquarters is located in Chicago, Illinois. It is named after co-founders J. Clydesdale Cushman and Bernard Wakefield.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

CWK vs EMR — Head-to-Head

Bigger by revenue
EMR
EMR
1.5× larger
EMR
$4.3B
$2.9B
CWK
Growing faster (revenue YoY)
CWK
CWK
+6.8% gap
CWK
10.8%
4.0%
EMR
Higher net margin
EMR
EMR
14.7% more per $
EMR
13.9%
-0.8%
CWK
More free cash flow
EMR
EMR
$367.7M more FCF
EMR
$602.0M
$234.3M
CWK
Faster 2-yr revenue CAGR
CWK
CWK
Annualised
CWK
15.5%
-0.4%
EMR

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CWK
CWK
EMR
EMR
Revenue
$2.9B
$4.3B
Net Profit
$-22.4M
$606.0M
Gross Margin
53.2%
Operating Margin
6.1%
Net Margin
-0.8%
13.9%
Revenue YoY
10.8%
4.0%
Net Profit YoY
-119.8%
2.2%
EPS (diluted)
$-0.10
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CWK
CWK
EMR
EMR
Q1 26
$4.3B
Q4 25
$2.9B
$4.3B
Q3 25
$2.6B
$4.9B
Q2 25
$2.5B
$4.6B
Q1 25
$2.3B
$4.4B
Q4 24
$2.6B
$4.2B
Q3 24
$2.3B
$4.6B
Q2 24
$2.3B
$4.4B
Net Profit
CWK
CWK
EMR
EMR
Q1 26
$606.0M
Q4 25
$-22.4M
$605.0M
Q3 25
$51.4M
$637.0M
Q2 25
$57.3M
$586.0M
Q1 25
$1.9M
$485.0M
Q4 24
$112.9M
$585.0M
Q3 24
$33.7M
$996.0M
Q2 24
$13.5M
$329.0M
Gross Margin
CWK
CWK
EMR
EMR
Q1 26
53.2%
Q4 25
53.2%
Q3 25
51.9%
Q2 25
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
51.3%
Q2 24
52.8%
Operating Margin
CWK
CWK
EMR
EMR
Q1 26
Q4 25
6.1%
17.8%
Q3 25
4.1%
16.4%
Q2 25
4.9%
16.1%
Q1 25
2.0%
14.2%
Q4 24
6.6%
18.6%
Q3 24
3.2%
14.7%
Q2 24
3.1%
10.4%
Net Margin
CWK
CWK
EMR
EMR
Q1 26
13.9%
Q4 25
-0.8%
13.9%
Q3 25
2.0%
13.1%
Q2 25
2.3%
12.9%
Q1 25
0.1%
10.9%
Q4 24
4.3%
14.0%
Q3 24
1.4%
21.6%
Q2 24
0.6%
7.5%
EPS (diluted)
CWK
CWK
EMR
EMR
Q1 26
$1.07
Q4 25
$-0.10
$1.07
Q3 25
$0.22
$1.12
Q2 25
$0.25
$1.04
Q1 25
$0.01
$0.86
Q4 24
$0.49
$1.02
Q3 24
$0.14
$1.74
Q2 24
$0.06
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CWK
CWK
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$784.2M
$1.7B
Total DebtLower is stronger
$2.7B
$13.4B
Stockholders' EquityBook value
$2.0B
$20.3B
Total Assets
$7.7B
$41.9B
Debt / EquityLower = less leverage
1.40×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CWK
CWK
EMR
EMR
Q1 26
$1.7B
Q4 25
$784.2M
Q3 25
$634.4M
Q2 25
$618.2M
Q1 25
$623.2M
Q4 24
$793.3M
Q3 24
$775.4M
Q2 24
$567.3M
Total Debt
CWK
CWK
EMR
EMR
Q1 26
$13.4B
Q4 25
$2.7B
$7.6B
Q3 25
$2.8B
$8.9B
Q2 25
$3.0B
$8.3B
Q1 25
$3.0B
$8.2B
Q4 24
$3.0B
$6.6B
Q3 24
$3.1B
$7.7B
Q2 24
$3.1B
$7.1B
Stockholders' Equity
CWK
CWK
EMR
EMR
Q1 26
$20.3B
Q4 25
$2.0B
$20.3B
Q3 25
$2.0B
$20.3B
Q2 25
$1.9B
$19.9B
Q1 25
$1.8B
$19.2B
Q4 24
$1.8B
$20.5B
Q3 24
$1.7B
$21.6B
Q2 24
$1.6B
$20.8B
Total Assets
CWK
CWK
EMR
EMR
Q1 26
$41.9B
Q4 25
$7.7B
$41.9B
Q3 25
$7.7B
$42.0B
Q2 25
$7.6B
$42.5B
Q1 25
$7.4B
$42.0B
Q4 24
$7.5B
$42.6B
Q3 24
$7.5B
$44.2B
Q2 24
$7.3B
$45.6B
Debt / Equity
CWK
CWK
EMR
EMR
Q1 26
0.66×
Q4 25
1.40×
0.37×
Q3 25
1.45×
0.44×
Q2 25
1.57×
0.42×
Q1 25
1.70×
0.42×
Q4 24
1.73×
0.32×
Q3 24
1.81×
0.36×
Q2 24
1.91×
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CWK
CWK
EMR
EMR
Operating Cash FlowLast quarter
$257.3M
Free Cash FlowOCF − Capex
$234.3M
$602.0M
FCF MarginFCF / Revenue
8.0%
13.9%
Capex IntensityCapex / Revenue
0.8%
2.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$293.0M
$4.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CWK
CWK
EMR
EMR
Q1 26
Q4 25
$257.3M
$699.0M
Q3 25
$235.5M
$3.1B
Q2 25
$9.6M
$1.1B
Q1 25
$-162.0M
$241.0M
Q4 24
$115.2M
$777.0M
Q3 24
$196.1M
$3.3B
Q2 24
$21.8M
$1.1B
Free Cash Flow
CWK
CWK
EMR
EMR
Q1 26
$602.0M
Q4 25
$234.3M
$602.0M
Q3 25
$225.0M
$2.7B
Q2 25
$300.0K
$977.0M
Q1 25
$-166.6M
$154.0M
Q4 24
$105.9M
$694.0M
Q3 24
$186.7M
$2.9B
Q2 24
$10.0M
$998.0M
FCF Margin
CWK
CWK
EMR
EMR
Q1 26
13.9%
Q4 25
8.0%
13.9%
Q3 25
8.6%
54.9%
Q2 25
0.0%
21.5%
Q1 25
-7.3%
3.5%
Q4 24
4.0%
16.6%
Q3 24
8.0%
63.1%
Q2 24
0.4%
22.8%
Capex Intensity
CWK
CWK
EMR
EMR
Q1 26
2.2%
Q4 25
0.8%
2.2%
Q3 25
0.4%
8.9%
Q2 25
0.4%
2.0%
Q1 25
0.2%
2.0%
Q4 24
0.4%
2.0%
Q3 24
0.4%
9.1%
Q2 24
0.5%
2.1%
Cash Conversion
CWK
CWK
EMR
EMR
Q1 26
Q4 25
1.16×
Q3 25
4.58×
4.86×
Q2 25
0.17×
1.83×
Q1 25
-85.26×
0.50×
Q4 24
1.02×
1.33×
Q3 24
5.82×
3.35×
Q2 24
1.61×
3.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CWK
CWK

Equity Method Investment Nonconsolidated Investee Or Group Of Investees$1.8B61%
Other$1.1B39%

EMR
EMR

Segment breakdown not available.

Related Comparisons